UK

Upendra Kumar Jain

Active Director Director DIN 05259913
DIN 05259913 First appointment Mar 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Total affiliations 6 Since Mar 2018
Shareholding value •••• Premium profile

About Upendra Kumar Jain

Data last updated:

Upendra Kumar Jain is a Director at Indivirtus Healthcare Services Private Limited (since 2018), Director at Indivirtus Solutions Private Limited (since 2021) and Director at Indivirtus Ab7 Scribing & Rcm Private Limited (since 2022), and holds 3 more current directorships. The companies operate in Pharma, Business Services and Business Outsourcing. The 5 current companies with reported revenue have a combined latest revenue of ₹13.72 Cr; the largest is Indivirtus Healthcare Services Private Limited at ₹8.76 Cr (FY 2025).

DIN 05259913
Primary Designation Director
Industry Pharma
First Appointment 20 Mar 2018
Oldest Company Age 8 yrs
Largest company Indivirtus Healthcare Services Private Limited · ₹8.76 Cr (FY 2025)
Combined revenue ₹13.72 Cr across 5 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Mar 20182018₹8.76 Cr (FY 2025)Active
Indivirtus Solutions Private Limited U74900PB2021PTC052812
Director18 Feb 20212021₹3.17 Cr (FY 2025)Active
Director30 Jun 20222022₹93.2 Lakh (FY 2025)Active
Director16 Feb 20222022₹80.8 Lakh (FY 2025)Active
Director12 Jul 20242024₹5 Lakh (FY 2025)Active
Director21 May 20252025Active

Directorship timeline

Open interactive timeline →
Indivirtus Global Cro Private Limited
Indivirtus Solutions Private Limited
Indivirtus Strategic Solutions Private Limited
Indivirtus Ab7 Scribing & Rcm Private Limited
Premium access

Shareholding and investment profile for Upendra Kumar Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Upendra Kumar Jain

Upendra Kumar Jain currently holds 6 directorships: Indivirtus Healthcare Services Private Limited (Director, since 20 Mar 2018, revenue ₹8.76 Cr (FY 2025)); Indivirtus Solutions Private Limited (Director, since 18 Feb 2021, revenue ₹3.17 Cr (FY 2025)); Indivirtus Ab7 Scribing & Rcm Private Limited (Director, since 30 Jun 2022, revenue ₹93.2 Lakh (FY 2025)); Indivirtus Strategic Solutions Private Limited (Director, since 16 Feb 2022, revenue ₹80.8 Lakh (FY 2025)); Indivirtus Global Cro Private Limited (Director, since 12 Jul 2024, revenue ₹5 Lakh (FY 2025)); and 1 more.

Upendra Kumar Jain was first appointed on 20 Mar 2018 as Director at Indivirtus Healthcare Services Private Limited. The most recent appointment on record is 21 May 2025 at Indivirtus Ecological Services Private Limited.

The 5 current companies of Upendra Kumar Jain that report revenue have a combined latest revenue of ₹13.72 Cr: Indivirtus Healthcare Services Private Limited ₹8.76 Cr (FY 2025); Indivirtus Solutions Private Limited ₹3.17 Cr (FY 2025); Indivirtus Ab7 Scribing & Rcm Private Limited ₹93.2 Lakh (FY 2025); Indivirtus Strategic Solutions Private Limited ₹80.8 Lakh (FY 2025); Indivirtus Global Cro Private Limited ₹5 Lakh (FY 2025).

The current boards of Upendra Kumar Jain's companies include Seema Kanwar (Indivirtus Healthcare Services Private Limited), Veena Kumari (Indivirtus Healthcare Services Private Limited), Ashok Kumar Benial (Indivirtus Ab7 Scribing & Rcm Private Limited), Jyoti Parmar (Indivirtus Ab7 Scribing & Rcm Private Limited), Ashish Jain (Indivirtus Strategic Solutions Private Limited), Randeep Singh (Indivirtus Strategic Solutions Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available